Difference between revisions of "Team:UNOTT/HP/Silver"

Line 41: Line 41:
  
 
<h1>Bank of England Interview</h1>
 
<h1>Bank of England Interview</h1>
−
<p> <i> INTERVIEW BEGINS </p> </i>
+
<center>
−
<p> <i> Vikram: Let's begin the interview with a little bit of formalities, I'm Vikram and I will be taking this interview. I am the modeller for the iGEM of Nottingham. What is your name, your role and responsibilities? </p> </i>
+
<a href="https://2017.igem.org/File:T--UNOTT--Recording.zip">Download the full audio for the interview here</a>
−
<p> <i>Tinesh: Hi Vikram. My name is Tinesh, my current role, I have 3 roles at the moment, I am the vice president of a Californian based digital threat management company in London, where I run both the business development function and delivery function across the UK. In addition, I sit on the board of non-exec director for a British cyber company called State Private, and they are a business-consumer email encryption company. And finally, I own my own company Decipher Cyber which is a professional services and innovation led technology company.</p> </i>
+
</center>
−
<p> <i>Vikram: How do you think we can improve our idea or make it more robust? </p> </i>
+
<br> </br>
−
<p> <i>Tinesh: Having seen what I seen today, I don't necessarily think there are any improvements to made in the actual security element of it because from what I've seen it sits within the cyber from a label perspective but from a delivery perspective it doesn't because it's bacteria and it's impenetrable so I don't think we can improve on that but we will find that out soon enough </p> </i>
+
<p> TRANSCRIPT: </p>
−
<p> <i>Vikram: What things are you looking for when you look at key coli </p> </i>
+
<p>  Vikram: Let's begin the interview with a little bit of formalities, I'm Vikram and I will be taking this interview. I am the modeller for the iGEM of Nottingham. What is your name, your role and responsibilities? </p>  
−
<p> <i>Tinesh: For me, it would be applications for how we use this in a cooperate environment and as well, as potentially in an everyday scenario with an everyday person. So those 2 areas are two main areas which are key for me. </p> </i>
+
<p> Tinesh: Hi Vikram. My name is Tinesh, my current role, I have 3 roles at the moment, I am the vice president of a Californian based digital threat management company in London, where I run both the business development function and delivery function across the UK. In addition, I sit on the board of non-exec director for a British cyber company called State Private, and they are a business-consumer email encryption company. And finally, I own my own company Decipher Cyber which is a professional services and innovation led technology company.</p>  
−
<p> <i>Vikram: Do you think bacteria in a physical device is something people would be happy with? Do you think its safe? How could we improve safety? </p> </i>
+
<p>Vikram: How do you think we can improve our idea or make it more robust? </p>  
−
<p> <i>Tinesh: As long as the delivery model is easy to use and can be adopted by everyday people, that's my only concern. As far as the safety of it, it's contained in a capsule and as there are no issues with the capsule breaking and so on and so forth. But as long as its easily adoptable by an end user, I don't see a challenge. </p> </i>
+
<p>Tinesh: Having seen what I seen today, I don't necessarily think there are any improvements to made in the actual security element of it because from what I've seen it sits within the cyber from a label perspective but from a delivery perspective it doesn't because it's bacteria and it's impenetrable so I don't think we can improve on that but we will find that out soon enough </p>  
−
<p> <i>Vikram: If you were using the device, would you want to know everything about the science or would you be happy if someone told you it was safe? </p> </i>
+
<p>Vikram: What things are you looking for when you look at key coli </p> </i>
−
<p> <i>Tinesh: Myself, someone from cyber and someone from sciences would want to know the ins and outs but I think for most cooperates and commercial organisations, certainly mid-sized organisations, not really. First off, they wouldn't have people who understand science and the science behind it so it would be out their comfort zone so they would bring people in but, from a cyber perspective, if it hits certain markers, helps mitigates certain risks and adds extra measure of security control whether that be physical, building, access or authentication, then they wouldn't necessarily need to know the science. they would be comfortable to see it in a live environment, seeing it doing it's thing, it would be happy. </p> </i>
+
<p>Tinesh: For me, it would be applications for how we use this in a cooperate environment and as well, as potentially in an everyday scenario with an everyday person. So those 2 areas are two main areas which are key for me. </p> </i>
−
<p> <i>INTERVIEW TERMINATES. </i>  </p>
+
<p>Vikram: Do you think bacteria in a physical device is something people would be happy with? Do you think its safe? How could we improve safety? </p>  
 +
<p> Tinesh: As long as the delivery model is easy to use and can be adopted by everyday people, that's my only concern. As far as the safety of it, it's contained in a capsule and as there are no issues with the capsule breaking and so on and so forth. But as long as its easily adoptable by an end user, I don't see a challenge. </p> </i>
 +
<p> Vikram: If you were using the device, would you want to know everything about the science or would you be happy if someone told you it was safe? </p>  
 +
<p> Tinesh: Myself, someone from cyber and someone from sciences would want to know the ins and outs but I think for most cooperates and commercial organisations, certainly mid-sized organisations, not really. First off, they wouldn't have people who understand science and the science behind it so it would be out their comfort zone so they would bring people in but, from a cyber perspective, if it hits certain markers, helps mitigates certain risks and adds extra measure of security control whether that be physical, building, access or authentication, then they wouldn't necessarily need to know the science. they would be comfortable to see it in a live environment, seeing it doing it's thing, it would be happy. </p>  
 +
<p> INTERVIEW TERMINATES.   </p>
  
 
<h1>Tech Nottingham talk<h1>
 
<h1>Tech Nottingham talk<h1>

Revision as of 16:57, 1 November 2017



 

 

HUMAN PRACTICES: SILVER

 



Introduction

As part of our human practices, we aimed to educate the public about synthetic biology and our own project. We accomplished this through talking to the public at our University open days, news article interviews, and 'Tech Nottingham' public talks.

Also, we wanted some feedback from experts working in the field that our project would be applied to. After weeks of persistence, we managed to get an interview with an expert from the Bank of England.

Bank of England Interview

Download the full audio for the interview here


TRANSCRIPT:

Vikram: Let's begin the interview with a little bit of formalities, I'm Vikram and I will be taking this interview. I am the modeller for the iGEM of Nottingham. What is your name, your role and responsibilities?

Tinesh: Hi Vikram. My name is Tinesh, my current role, I have 3 roles at the moment, I am the vice president of a Californian based digital threat management company in London, where I run both the business development function and delivery function across the UK. In addition, I sit on the board of non-exec director for a British cyber company called State Private, and they are a business-consumer email encryption company. And finally, I own my own company Decipher Cyber which is a professional services and innovation led technology company.

Vikram: How do you think we can improve our idea or make it more robust?

Tinesh: Having seen what I seen today, I don't necessarily think there are any improvements to made in the actual security element of it because from what I've seen it sits within the cyber from a label perspective but from a delivery perspective it doesn't because it's bacteria and it's impenetrable so I don't think we can improve on that but we will find that out soon enough

Vikram: What things are you looking for when you look at key coli

Tinesh: For me, it would be applications for how we use this in a cooperate environment and as well, as potentially in an everyday scenario with an everyday person. So those 2 areas are two main areas which are key for me.

Vikram: Do you think bacteria in a physical device is something people would be happy with? Do you think its safe? How could we improve safety?

Tinesh: As long as the delivery model is easy to use and can be adopted by everyday people, that's my only concern. As far as the safety of it, it's contained in a capsule and as there are no issues with the capsule breaking and so on and so forth. But as long as its easily adoptable by an end user, I don't see a challenge.

Vikram: If you were using the device, would you want to know everything about the science or would you be happy if someone told you it was safe?

Tinesh: Myself, someone from cyber and someone from sciences would want to know the ins and outs but I think for most cooperates and commercial organisations, certainly mid-sized organisations, not really. First off, they wouldn't have people who understand science and the science behind it so it would be out their comfort zone so they would bring people in but, from a cyber perspective, if it hits certain markers, helps mitigates certain risks and adds extra measure of security control whether that be physical, building, access or authentication, then they wouldn't necessarily need to know the science. they would be comfortable to see it in a live environment, seeing it doing it's thing, it would be happy.

INTERVIEW TERMINATES.

Tech Nottingham talk